AFAP1 and non-small cell lung carcinoma: Consistent with these previous findings, we found that AFAP1-AS1 was upregulated in NSCLC tissues and cells, and it was overexpressed in chemotherapy-resistant tissues, indicating that AFAP1-AS1 is a positive regulator of NSCLC development and chemoresistance.